Improving Pregnancy Outcomes With Progesterone

PHASE3CompletedINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

February 7, 2018

Primary Completion Date

June 25, 2020

Study Completion Date

August 6, 2020

Conditions
Pre-term BirthHIV-1-infection
Interventions
DRUG

17P

Synthetic progestin

OTHER

Placebo

Non-active placebo comparator

Trial Locations (2)

Unknown

Kamwala District Clinic, Lusaka

University Teaching Hospital, Lusaka

Sponsors
All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

collaborator

AMAG Pharmaceuticals, Inc.

INDUSTRY

collaborator

Bill and Melinda Gates Foundation

OTHER

lead

University of North Carolina, Chapel Hill

OTHER